July 18, 2023 12:51 PM EDT
Pharma
Marketing

Mar­ket­ingRx roundup: Genen­tech, Bris­tol My­ers lead Fast Com­pa­ny in­no­va­tors list; Re­al Chem­istry inks AI deal  

Beth Snyder Bulik

Senior Editor

Genen­tech in the biotech cat­e­go­ry and Bris­tol My­ers Squibb in the phar­ma­ceu­ti­cal cat­e­go­ry notched top spots on Fast Com­pa­ny’s an­nu­al best work­places for in­no­va­tors …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

A service from the Financial Times